J. Meng

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.

W. Curran, K. Forster, P. Iyengar, 2015, The Lancet. Oncology.

Long-Term Results of RTOG 0617: A Randomized Phase 3 Comparison of Standard Dose Versus High Dose Conformal Chemoradiation Therapy +/- Cetuximab for Stage III NSCLC

W. Curran, K. Forster, P. Iyengar, 2017 .

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.

K. Forster, P. Iyengar, H. Choy, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Do-Hoon Kim, R. Vandermeer, T. Whelan, 2019, The Lancet.

Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617.

W. Curran, J. Bradley, C. Robinson, 2016, Journal of the National Cancer Institute.

IMRT sparing of normal tissues in locoregional treatment of breast cancer

J. Caudrelier, K. Amjadi, J. Meng, 2014, Radiation oncology.